Table 6.

Effects of mobilization by granulocyte colony-stimulating factor on the prognitors in the muscle and peripheral blood

ColonyPB (per mL)Muscle (per 2 hind legs)
G-CSF(−)G-CSF(+)G-CSF(−)G-CSF(+)
BFU-E 18 ± 6 216 ± 1266-150 3 ± 2 2 ± 2 
GEMM 4 ± 0 83 ± 336-151 1 ± 1 1 ± 1 
GM 42 ± 8 1013 ± 2566-151 136 ± 9 138 ± 11 
Total 74 ± 5 1594 ± 2366-151 158 ± 15 157 ± 11 
ColonyPB (per mL)Muscle (per 2 hind legs)
G-CSF(−)G-CSF(+)G-CSF(−)G-CSF(+)
BFU-E 18 ± 6 216 ± 1266-150 3 ± 2 2 ± 2 
GEMM 4 ± 0 83 ± 336-151 1 ± 1 1 ± 1 
GM 42 ± 8 1013 ± 2566-151 136 ± 9 138 ± 11 
Total 74 ± 5 1594 ± 2366-151 158 ± 15 157 ± 11 

Peripheral blood and muscles were collected from 6 mice that received G-CSF treatment and 6 control mice without G-CSF treatment. After Percoll density-gradient separation, mononuclear cells were cultured in methylcellulose in the presence of thrombopoietin, steel factor, erythropoietin, IL-3, granulocyte/macrophage CSF. On day 8 of culture, colonies were counted. Data represent the mean and SD of values based on the results obtained from 4 dishes. Two additional experiments showed similar results.

PB indicates peripheral blood; G-CSF, granulocyte colony-stimulating factor; BFU-E, erythroid burst-forming units; GEMM, mixed colonies containing erythroid and myeloid cells and megakaryocytes; and GM, granulocyte and/or macrophage colonies.

F6-150

P < .05, as compared with the control mice.

F6-151

P < .01, as compared with the control mice.